Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Ability of Alpha-GST to Detect Graft Primary Dysfunction After Liver Transplantation

NCT02451046 is registered in ClinicalTrials.gov with Beaujon Hospital as lead sponsor.

NCT NCT02451046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02451046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Ability of Alpha-GST to Detect Graft Primary Dysfunction After Liver Transplantation
Lead sponsor
Beaujon Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2014
Completion date
October 31, 2015
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

evidence of liver transplantation